Correspondence 0001493152-24-043458 from Basel Medical Group Ltd (BMGL)
Basel Medical Group Ltd
Date: Nov. 4, 2024 · CIK: 0002004489 · Accession: 0001493152-24-043458
AI Filing Summary & Sentiment
File numbers found in text: 333-282096
Show Raw Text
CORRESP
1
filename1.htm
Basel
Medical Group Ltd
6
Napier Road,
Unit
#02-10/11 Gleneagles Medical Centre
Singapore
258499
Date:
November 4, 2024
Via
EDGAR
Division
of Corporation Finance
Office
of Energy & Transportation
U.S.
Securities and Exchange Commission
Washington,
D.C. 20549
Attn.:
Nudrat
Salik
Michael
Fay
Robert
Augustin
Jane
Park
Re:
Basel
Medical Group Ltd
Registration
Statement on Form F-1
Filed
September 13, 2024
CIK
No. 0002004489
File
No. 333-282096
Ladies
and Gentlemen:
Basel
Medical Group Ltd (the “Company”) is publicly filing its first amendment to the registration statement on Form F-1
(the “Registration Statement”) with the U.S. Securities and Exchanges Commission to update its financial, offering
and other information.
Kindly
address any comments or questions that you have concerning the Registration Statement to our attorneys Benjamin Tan Esq. and Martryn
Mak Esq. of Sichenzia Ross Ference Carmel LLP at (646) 810-0609 or btan@srfc.law and (646) 963-6393 or mmak@srfc.law.
Thank
you for your time and attention.
Very
truly yours,
For
and on behalf of
Basel
Medical Group Ltd
/s/
Raymond Wai Man Cheung
Name:
Raymond
Wai Man Cheung
Position:
Chief
Executive Officer